Liu, J., Zhang, J., Li, H., Song, G., Di, L., Jiang, H., . . . Li, Q. Anlotinib in combination with metronomic chemotherapy in HER2-negative metastatic breast cancer: An observational and retrospective study. BMC.
Chicago Style (17th ed.) CitationLiu, Jiaxuan, et al. Anlotinib in Combination with Metronomic Chemotherapy in HER2-negative Metastatic Breast Cancer: An Observational and Retrospective Study. BMC.
MLA (9th ed.) CitationLiu, Jiaxuan, et al. Anlotinib in Combination with Metronomic Chemotherapy in HER2-negative Metastatic Breast Cancer: An Observational and Retrospective Study. BMC.
Warning: These citations may not always be 100% accurate.